Reagents
Sustainable recombinant endotoxin detection assay
Jul 03 2024
Introducing PYROSTAR™ Neo+ from Alpha Laboratories
In line with its sustainability ethics, Alpha Laboratories is delighted to introduce the new PYROSTAR™ Neo+ from FUJIFILM Wako. This endotoxin detection reagent has been developed by recombinant technology to provide a synthetic LAL assay alternative, designed with wildlife conservation in mind. This innovative product offers a non-animal derived solution for bacterial endotoxin testing (BET) in research, pharmaceutical, and medical equipment manufacturing. By replacing conventional LAL reagents sourced from Atlantic Horseshoe Crabs, PYROSTAR™ Neo+ helps reduce the impact on wildlife, while facilitating the same high sensitivity as PYROSTAR™ ES-F.
PYROSTAR™ Neo+ utilises a recombinant 3 Factor system that replicates the equivalent cascade reaction of traditional LAL assays. It boasts improved specificity with the absence of Factor G, and eliminates interference due to reaction with β-glucan. Additionally, it has an optimised formulation to support handling of difficult sample matrices which cause interference.
The Neo+ reagent contains a pNA chromogenic group, enabling detection of the assay results on an absorbance plate reader using a colorimetric method recombinant cascade reagent (rCR) assay. The endotoxin test offers clear ethical and environmental advantages over the traditional LAL test, including its compliance with the 3Rs principles of replacement, reduction, and refinement of animal testing.
For a limited time only, save 10% off Neo+. Visit the website or quote offer code PN0724. Offer ends 31st October 2024.
More information online
Digital Edition
International Labmate 49.6 - Sept 2024
September 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan